Step-by-Step strategy aims to boost use of opioid addiction medications in clinics
NCT ID NCT05343793
First seen Jul 06, 2026 · Last updated Jul 24, 2026 · Updated 3 times
Summary
This study tests a staged approach to help addiction treatment programs in Washington State increase their use of medications for opioid use disorder (MOUD). Clinics start with simple feedback reports and, if needed, move to more intensive support like workshops and coaching. The goal is to see which combination of strategies works best to get more patients started on and staying with medications like buprenorphine or naltrexone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Enhanced Monitoring and Feedback, NIATx/MAT Academy, Internal and External Facilitation
- What this could lead to
- If successful, this approach could help more addiction clinics nationwide adopt medications for opioid use disorder, improving treatment access and patient outcomes.
- What could go wrong
- This is an implementation study, not a drug trial. It tests how to change clinic behavior, not a new treatment. Results may vary across clinics and may not apply outside Washington State.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADDICTION, OPIOID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington State Healthcare Authority
Olympia, Washington, 98501, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.